Radiofrequency ablation of breast cancer. First report of an emerging technology

Archives of Surgery

Volumn 134, Issue 10, 1999, Pages 1064-1068

  Jeffrey, Stefanie S ^a   Birdwell, Robyn L ^a   Ikeda, Debra M ^a,c   Daniel, Bruce L ^a   Nowels, Kent W ^a   Dirbas, Frederick M ^a   Griffey, Stephen M ^b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c RadioTherapeutics Corp   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIHYDROLIPOAMIDE DEHYDROGENASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER CELL; CELL DEATH; CELL VIABILITY; CLINICAL ARTICLE; DATA ANALYSIS; ELECTROSURGERY; FEMALE; HOSPITAL CARE; HUMAN; PRIORITY JOURNAL; RADIOFREQUENCY;

ADULT; AGED; BREAST NEOPLASMS; ELECTROCOAGULATION; FEMALE; HUMANS; MIDDLE AGED; NEEDLES; PROSPECTIVE STUDIES;

EID: 0032850577     PISSN: 00040010     EISSN: None     Source Type: Journal    
DOI: 10.1001/archsurg.134.10.1064     Document Type: Article

References (37)

1. Fisher B. The evolution of paradigms for the management of breast cancer: a personal perspective. Cancer Res. 1992;52:2371-2383.
2. Halsted WS. The results of operations for the cure of cancer of the breast performed at the Johns Hopkins Hospital from June, 1889, to January, 1894. Ann Surg. 1894;20:497-555.
3. Halsted WS. The results of radical operations for the cure of carcinoma of the breast. Ann Surg. 1907;46:1-19.
4. Robinson GN, Van Heerden JA, Payne WS, Taylor WF, Gaffey TA. The primary surgical treatment of carcinoma of the breast: a changing trend toward modified radical mastectomy. Mayo Clin Proc. 1976;51:433-442.
5. Baker RR, Montague ACW, Childs JN. A comparison of modified radical mastectomy to radical mastectomy in the treatment of operable breast cancer. Ann Surg. 1979;189:553-559.
6. Turner L, Swindell R, Bell WGT, et al. Radical versus modified radical mastectomy for breast cancer. Ann R Coll Surg Engl. 1981;63:239-243.
7. Maddox WA, Carpenter JT Jr, Laws HL, et al. A randomized prospective trial of radical (Halsted) mastectomy versus modified radical mastectomy in 311 breast cancer patients. Ann Surg. 1983;198:207-212.
8. Recht A, Connolly JL, Schnitt SJ, et al. Conservative surgery and radiation therapy for early breast cancer: results, controversies, and unsolved problems. Semin Oncol. 1986;13:434-449.
9. Sarrazin D, Lê MG, Arriagada R, et al. Ten-year results of a randomized trial comparing a conservative treatment to mastectomy in early breast cancer. Radiother Oncol. 1989;14:177-184.
10. Fisher B, Redmond C, Poisson R, et al. Eight-year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med. 1989;320:822-828.
11. Veronesi U, Banfi A, Salvadori B, et al. Breast conservation is the treatment of choice in small breast cancer: long-term results of a randomized trial, Eur J Cancer. 1990;26:668-670.
12. Veronesi U, Salvadori A, Luini A, et al. Conservative treatment of early breast cancer: long-term results of 1232 cases treated with quadrantectomy, axillary dissection, and radiotherapy. Ann Surg. 1990;211:250-259.
13. Lichter AS, Lippman ME, Danforth DN, et al. Mastectomy versus breast-conserving therapy in the treatment of stage I and II carcinoma of the breast: a randomized trial at the National Cancer Institute. J Clin Oncol. 1992;10:976-983.
14. Blichert-Toft M, Rose C, Andersen JA, et al. Danish randomized trial comparing breast conservation therapy with mastectomy: six years of life-table analysis. J Natl Cancer Inst Monogr. 1992;11:19-25.
15. Van Dongen JA, Bartelink H, Fentiman IS, et al. Randomized clinical trial to assess the value of breast-conserving therapy in stage I and II breast cancer, EORTC 10801 trial. J Natl Cancer Inst Monogr. 1992;11:15-18.
16. Rand RW, Rand RP, Eggerding F, DenBesten L, King W. Cryolumpectomy for carcinoma of the breast. Surg Gynecol Obstet. 1987;165:392-396.
17. Staren ED, Sabel M, Gianakakis LM, et al. Cryosurgery of breast cancer. Arch Surg. 1997;132:28-33.
18. Mumtaz H, Hall-Craggs MA, Wotherspoon A, et al. Laser therapy for breast cancer: MR imaging and histopathologic correlation. Radiology. 1996;200:651-658.
19. Harari PM, Hynynen KH, Roemer RB, et al. Development of scanned focussed ultrasound hyperthermia: clinical response evaluation. Int J Radiat Oncol Biol Phys. 1991;21:831-840.
20. Hill CR, ter Haar GR. High intensity focused ultrasound - potential for cancer treatment. Br J Radiol. 1995;68:1296-1303.
21. LeVeen RF. Laser hyperthermia and radiofrequency ablation of hepatic lesions. Semin Intery Radiol. 1997;14:313-324.
22. Zlotta AR, Djavan B, Matos C, et al. Percutaneous transperineal radiofrequency ablation of prostate tumour: safety, feasibility and pathological effects on human prostate cancer. Br J Urol. 1998;81:265-275.
23. Rosenthal DI, Horniecek FJ, Wolfe MW, Jennings LC, Gebhardt MC, Mankin HJ. Percutaneous radiofrequency coagulation of osteoid osteoma compared with operative treatment. J Bone Joint Surg Am. 1998;80:815-821.
24. Zlotta AR, Wildschutz T, Raviv G, et al. Radiofrequency interstitial tumor ablation (RITA) is a possible new modality for treatment of renal cancer: ex vivo and in vivo experience. J Endourol. 1997;11:251-258.
25. Powell NB, Riley RW, Troell RJ, Li K, Blumen MB, Guilleminault C. Radiofrequency volumetric tissue reduction of the palate in subjects with sleep-disordered breathing. Chest. 1998;113:1163-1174.
26. Wilkinson HA. Percutaneous radiofrequency upper thoracic sympathectomy. Neurosurgery. 1996;38:715-725.
27. Baron MS, Vitek JL, Bakay RA, et al. Treatment of advanced Parkinson's disease by posterier GPi pallidotomy: 1-year results of a pilot study. Ann Neurol. 1996; 40:355-366.
28. Neumann RA, Knobler RM, Pieczkowski F, Gebhart W. Enzyme histochemical analysis of cell viability after argon laser-induced coagulation necrosis of the skin. J Am Acad Dermatol. 1991;25:991-998.
29. Gage AA. Cryosurgery in the treatment of cancer. Surg Gynecol Obstet. 1992; 174:73-92.
30. Rockwell AD. Electro-surgery: benign and malignant tumors. In: Rockwell AD. The Medical and Surgical Uses of Electricity. New York, NY: EB Treat & Co; 1903: 565-566.
31. Onik GM, Cohen JK, Reyes GD, Rubinsky B, Chang ZH, Baust J. Transrectal ultrasound-guided percutaneous radical cryosurgical ablation of the prostate. Cancer. 1993;72:1291-1299.
32. Wong WS, Chinn DO, Chinn M, Chinn J, Tom WL, Tom WL. Cryosurgery as a treatment for prostate carcinoma: results and complications. Cancer. 1997;79:963-974.
33. Organ LW. Electrophysiologic principles of radiofrequency lesion making. Appl Neurophysiol. 1976/77;39:69-76.
34. Dickson JA, Calderwood SK. Temperature range and selective sensitivity of tumors to hyperthermia: a critical review. Ann N Y Acad Sci. 1980;335:180-205.
35. Liu F-F, Wilson BC. Hyperthermia and photodynamic therapy. In: Tannock IF, Hill RP, eds. The Basic Science of Oncology. New York, NY: McGraw-Hill Book Co; 1998:443-453.
36. Rhee JG, Song CW. Thermotolerance of organized tissues and tumors. In: Henle KJ, ed. Thermotolerance. Vol 1. Boca Raton, Fla: CRC Press Inc; 1987:73-95.
37. Jossinet J. Variability of impedivity in normal and pathological breast tissue. Med Biol Eng Comput. 1996;34:346-350.